BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31601793)

  • 1. Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways.
    Zhang X; Hou G; Liu A; Xu H; Guan Y; Wu Y; Deng J; Cao X
    Cell Death Dis; 2019 Oct; 10(10):770. PubMed ID: 31601793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells.
    Du J; Li J; Song D; Li Q; Li L; Li B; Li L
    Mol Med Rep; 2020 Nov; 22(5):3659-3666. PubMed ID: 33000249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling.
    Zou Y; Sarem M; Xiang S; Hu H; Xu W; Shastri VP
    BMC Cancer; 2019 Oct; 19(1):949. PubMed ID: 31615459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK.
    Liang X; Ju J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role and mechanism of matrine alone and combined with acitretin for HaCaT cells and psoriasis-like murine models.
    Jiang WW; Wang YM; Wang XY; Zhang Q; Zhu SM; Zhang CL
    Chin Med J (Engl); 2019 Sep; 132(17):2079-2088. PubMed ID: 31460901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrine induces apoptosis and autophagy in human lung adenocarcinoma cells via upregulation of Cavin3 and suppression of PI3K/AKT pathway.
    Wan Q; Du Z; Fang Z; Cheng H; Li C; Zhou X
    J BUON; 2020; 25(3):1512-1516. PubMed ID: 32862598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways.
    Liu Y; Qi Y; Bai ZH; Ni CX; Ren QH; Xu WH; Xu J; Hu HG; Qiu L; Li JZ; He ZG; Zhang JP
    Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
    Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
    Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways.
    Zhang X; Xu H; Bi X; Hou G; Liu A; Zhao Y; Wang G; Cao X
    Cell Death Dis; 2021 Oct; 12(10):931. PubMed ID: 34642304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
    Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo.
    Liu T; Song Y; Chen H; Pan S; Sun X
    Biol Pharm Bull; 2010; 33(10):1740-5. PubMed ID: 20930385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation.
    Zhang S; Zhang Y; Zhuang Y; Wang J; Ye J; Zhang S; Wu J; Yu K; Han Y
    PLoS One; 2012; 7(10):e46853. PubMed ID: 23056487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
    Qian L; Liu Y; Xu Y; Ji W; Wu Q; Liu Y; Gao Q; Su C
    Cancer Lett; 2015 Nov; 368(1):126-134. PubMed ID: 26259512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrine inhibits the invasive properties of human osteosarcoma cells by downregulating the ERK-NF-κB pathway.
    Li Y; Zhang ZN; Zhao HM; Tong ZC; Yang J; Wang H; Liang XJ
    Anticancer Drugs; 2014 Oct; 25(9):1035-43. PubMed ID: 24999836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrine Exerts Antidepressant-Like Effects on Mice: Role of the Hippocampal PI3K/Akt/mTOR Signaling.
    Wu Z; You Z; Chen P; Chen C; Chen F; Shen J; Xu H
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):764-776. PubMed ID: 29668939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway.
    Zhou W; Wang J; Qi Q; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Bjerkvig R; Li X; Wang J
    Cancer Med; 2018 Sep; 7(9):4729-4743. PubMed ID: 30079478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrine induces autophagy in human neuroblastoma cells via blocking the AKT-mTOR pathway.
    Liu N; Yang C; Yang L; Li T; Gong M; Wang H; Zhang J; Zhao H; Zou L; He X
    Med Oncol; 2022 Aug; 39(11):167. PubMed ID: 35972593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrine reversed multidrug resistance of breast cancer MCF-7/ADR cells through PI3K/AKT signaling pathway.
    Zhou BG; Wei CS; Zhang S; Zhang Z; Gao HM
    J Cell Biochem; 2018 May; 119(5):3885-3891. PubMed ID: 29130495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
    Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
    Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K/AKT signaling pathways.
    Sun X; Zhuo XB; Hu YP; Zheng X; Zhao QJ
    Mol Cell Biochem; 2018 Dec; 449(1-2):47-54. PubMed ID: 29532226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.